chrisvoncsefalvay/vaers-outcomes huggingface dataset:
low grade fever of 100 degrees; scarring; pulling at her left chest; lung pleurisy (inflammation of lung lining); excruciating pain; This spontaneous case was reported by a consumer and describes the occurrence of SCAR (scarring), CHEST DISCOMFORT (pulling at her left chest), PLEURISY (lung pleurisy (inflammation of lung lining)), PAIN (excruciating pain) and PYREXIA (low grade fever of 100 degrees) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, the patient experienced PYREXIA (low grade fever of 100 degrees). In 2021, the patient experienced SCAR (scarring), CHEST DISCOMFORT (pulling at her left chest), PLEURISY (lung pleurisy (inflammation of lung lining)) and PAIN (excruciating pain). The patient was treated with PARACETAMOL (TYLENOL) in February 2021 at a dose of 1 dosage form and MELOXICAM in February 2021 at a dose of 1 dosage form. At the time of the report, SCAR (scarring) and CHEST DISCOMFORT (pulling at her left chest) had not resolved and PLEURISY (lung pleurisy (inflammation of lung lining)), PAIN (excruciating pain) and PYREXIA (low grade fever of 100 degrees) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: 100 (High) low grade fever of 100 degrees.         No Concomitant product use was provided by the reporter.   Lab data included CT with contrast and chest x ray result was unknown.
Pt died 6 days after receiving vaccines. 7/21/05 Received medical records from ER which revealed patient arrived in full arrest & unable to resuscitate.  Parent reported mild upper respiratory symptoms for a few days prior to death.
patient was moaning; hallucinations; he could barely speak/not really talking and not really responding; Alice In Wonderland Syndrome; bad headeache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 9 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Dec2021 14:30 (Lot number: FK5127) at the age of 9 years as dose 1, 10 ug single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: HALLUCINATION (medically significant) with onset 15Dec2021, outcome "recovering", described as "hallucinations"; SPEECH DISORDER (non-serious) with onset 14Dec2021 21:00, outcome "recovering", described as "he could barely speak/not really talking and not really responding"; ALICE IN WONDERLAND SYNDROME (non-serious) with onset 14Dec2021 21:00, outcome "recovering", described as "Alice In Wonderland Syndrome"; MOANING (non-serious), outcome "unknown", described as "patient was moaning"; HEADACHE (non-serious) with onset 14Dec2021 21:00, outcome "recovering", described as "bad headeache". The events "hallucinations", "he could barely speak/not really talking and not really responding", "alice in wonderland syndrome" and "bad headeache" were evaluated at the physician office visit. Therapeutic measures were not taken as a result of hallucination, speech disorder, alice in wonderland syndrome, headache. The Clinical course: Had a really bad headache for two days: The patient received the Pfizer Vaccine for kids 5 to 11 on 13Dec2021 and that night went to sleep. The next night, 14Dec2021, later in the night, the patient just laid there and said head hurt and not really talking and not really responding. The caller states caller woke up because the patient was moaning. The headache went away and lasted two days. The caller states the patient did not recover completely.Started to hallucinate and this was called Alice in wonderland syndrome: The patient still has Alice in wonderland syndrome. Everything looks small. The caller clarifies this began on 15Dec2021. The patient's Alice in wonderland syndrome has improved but is still having to check with the patient. The patient still has a spark, will watch something and everything gets small.patient had not received any other vaccines within 4 weeks prior to the COVID vaccine  No follow-up attempts are possible. No further information is expected.
Woke up at 4:45 to get ready for work and body felt achy throughout my whole body. Neck, arms, legs, back. I also had a headache throughout the whole day. When I got home around 7:15-7:30 I checked my temp oral and tympanic. Both read between 102.5-103 orally and in both ears. Took 600 mg of ibuproven
headache, highfever, chills, nausea, swollen arm (red/ hot to touch) skin sensitivity, body / joint aches
Throat tightness; Outbreak on chest; Short of breath; Lymph node in neck; UTI; chills; back ache; Leg swelling; cough; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Lymph node in neck), CHILLS (chills), URINARY TRACT INFECTION (UTI), THROAT TIGHTNESS (Throat tightness) and RASH (Outbreak on chest) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypertension (medical history: hypertension, start/ stop date not given). Concomitant products included AZITHROMYCIN (Phenazopyridine) for UTI.   On 05-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 07-Jan-2021, the patient experienced COUGH (cough) and PERIPHERAL SWELLING (Leg swelling). On 08-Jan-2021, the patient experienced CHILLS (chills) and BACK PAIN (back ache). On 09-Jan-2021, the patient experienced LYMPHADENOPATHY (Lymph node in neck) and URINARY TRACT INFECTION (UTI). On 03-Feb-2021, the patient experienced DYSPNOEA (Short of breath). On 04-Feb-2021, the patient experienced RASH (Outbreak on chest). On 05-Feb-2021, the patient experienced THROAT TIGHTNESS (Throat tightness). On 11-Jan-2021, BACK PAIN (back ache) had resolved. On 12-Jan-2021, LYMPHADENOPATHY (Lymph node in neck), CHILLS (chills) and COUGH (cough) had resolved. On 19-Jan-2021, URINARY TRACT INFECTION (UTI) had resolved. On 30-Jan-2021, PERIPHERAL SWELLING (Leg swelling) had resolved. At the time of the report, THROAT TIGHTNESS (Throat tightness), RASH (Outbreak on chest) and DYSPNOEA (Short of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient consulted HCP on 29 JAN 2021 and no treatment was prescribed
This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (muscle spasm or cramp in right leg), DIARRHEA (diarrhea), TENDERNESS (Feels a similar tenderness or soreness as she did after getting the shot), CHILLS (Experienced chills) and NAUSEA (Nausea) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 08-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced CHILLS (Experienced chills), NAUSEA (Nausea), MYALGIA (Muscle pain) and FATIGUE (Felt a little tired). On 13-May-2021, the patient experienced MUSCLE SPASMS (muscle spasm or cramp in right leg) and DIARRHEA (diarrhea). On 15-May-2021, the patient experienced TENDERNESS (Feels a similar tenderness or soreness as she did after getting the shot). At the time of the report, MUSCLE SPASMS (muscle spasm or cramp in right leg), DIARRHEA (diarrhea), TENDERNESS (Feels a similar tenderness or soreness as she did after getting the shot), CHILLS (Experienced chills), NAUSEA (Nausea), MYALGIA (Muscle pain) and FATIGUE (Felt a little tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications reported by investigator. Her sister helped her massage her leg cramp is the treatment medication reported.
Area of injection is red, small inflammation. It was black and bleeding. It has no healed as of today's date 02/03/05. Is healing.
Prior to her 12 month vaccines, patient was saying 5 words and babbling non stop. About 2 weeks after her 12 month vaccines, I noticed she had stopped talking altogether. She was no longer saying her 5 words and had stopped babbling as well. She also quit responding to her name and stated displaying some concerning behaviors such as flapping her hands/wrists, banging her head against the wall, and staring off into space.
At 8:50 AM she developed nausea, diffuse headache, malaise, tingling of her hands, elevated blood pressure and metal taste in mouth.  She denied any trouble breathing. No swallowing difficulty, swelling of the tongue or lips observed.  Subject stated she did not feel safe driving and was brought to ED by EMS.  She has a history of fibromuscular dysplasia and is on aspirin and Plavix.  Emergency Department ASSESSMENT and PLAN This is a 58 y.o. female who presents with vaccination side effects.  She is well-appearing on exam.  There is no evidence of airway swelling or anaphylaxis.  Will observe. 11:34 AM Has been observed for 2 hours and her symptoms have not worsened.  She did take her own dose of Tylenol for headache.  She is comfortable returning home.  She does have the Moderna fact sheet and we discussed signs and symptoms of when to return.  She is comfortable with plan.  All questions were answered."
Information was received on 25-APR-2017 from a nurse practitioner regarding multiple unspecified patients. Medical history, concurrent conditions and concomitant medications were not reported. On multiple unspecified dates, multiple unspecified patients were vaccinated with improperly stored RECOMBIVAX HB (lot # unknown) (dose not specified). No adverse effects were reported. The action taken was not applicable and the outcome was unknown. Excursion information: Vaccine involved: RECOMBIVAX HB Temperature: 33.0 degrees Fahrenheit Time Frame: 40 minutes. Previous temperature excursion? Yes, 34.8 degrees Fahrenheit for 21 minutes. Was call because of a "data logger"? Yes. No further information was provided. Additional information has been requested.
Off/on pressure in chest started Oct 4, 2021 for approximately 5 days and Shortness of breath.  Tingle  in left hand and fingers (15 mins after shot)  Off/on Left finger tips and hand pain still ongoing.  I was seen at Urgent Care on Oct 6, 2021. Recommended ER and heart specialist  for additional testing.
Information has been received from a physician concerning an 11 month old male who on 27-FEB-2007 was vaccinated with Rotateq PO "the last dose". The patient developed an intussusception and was hospitalized. Subsequently, the patient recovered from intussusception. Intussusception was considered to be disabling, life threatening and caused hospitalization. Additional information has been requested. 10/5/07-records received from facility for DOS 5/23-5/25/07-Seen in ER. DX:Intussusception-reducted by fluoroscopically guided air enema. HX of abdominal pain and bloody stools this morning,
AT 5 PM AFTER SHOT COULDN'T BEND ARM.  99 DEGREE FEVER.  THREW UP SEVERAL TIMES.  SWELLING ALL OVER BODY.  COULDN'T USE ARM FOR 4 DAYS BECAUSE IT WAS COMPLETELY LOCKED UP.  GOT STEROID SHOT AND ZPAK AS A  RESULT.
FEELING A LITTLE BIT WIERD; difficulty breathing; MEASURED HEART BEAT HAS BEEN VARIABLE; DISBALANCE; FATIGUE; MUSCLE PAIN; JOINT PAIN; A LITTLE BIT OF PAIN AT THE INJECTION SITE; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE IRREGULAR (MEASURED HEART BEAT HAS BEEN VARIABLE), DYSPNOEA (difficulty breathing), FEELING ABNORMAL (FEELING A LITTLE BIT WIERD), BALANCE DISORDER (DISBALANCE) and VACCINATION SITE PAIN (A LITTLE BIT OF PAIN AT THE INJECTION SITE) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M207) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension, Sciatic hernia, Stress (stress disorder) and Prostate infection. Concomitant products included METOPROLOL for Hypertension, ACETYLSALICYLIC ACID (ASPRIN), FISH OIL, OENOTHERA BIENNIS OIL, TOCOPHERYL ACETATE (OMEGA 3 & 6) and CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) for an unknown indication.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION SITE PAIN (A LITTLE BIT OF PAIN AT THE INJECTION SITE). On 18-Feb-2021, the patient experienced HEART RATE IRREGULAR (MEASURED HEART BEAT HAS BEEN VARIABLE), BALANCE DISORDER (DISBALANCE), FATIGUE (FATIGUE), MYALGIA (MUSCLE PAIN) and ARTHRALGIA (JOINT PAIN). On 19-Feb-2021, the patient experienced DYSPNOEA (difficulty breathing). On 22-Feb-2021, the patient experienced FEELING ABNORMAL (FEELING A LITTLE BIT WIERD). At the time of the report, HEART RATE IRREGULAR (MEASURED HEART BEAT HAS BEEN VARIABLE), DYSPNOEA (difficulty breathing), FEELING ABNORMAL (FEELING A LITTLE BIT WIERD), BALANCE DISORDER (DISBALANCE), FATIGUE (FATIGUE), MYALGIA (MUSCLE PAIN) and ARTHRALGIA (JOINT PAIN) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Tazulozil 0.4 mg for prostate.   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2021: Follow-up received on 22-02-2021: No new information
C/o itching on injection arm, chest constriction, and cough and throat tightening, reported back to health unit. Given 50ml Benadryl IM, O2 per mask and 911 called. Transported to ER via EMS.
Cant think; Pain in arm; Fuzzy head; Arm pain,achy and everything,bodyache; slight headache; chills; feeling nauseous; This spontaneous case was reported by a consumer and describes the occurrence of MENTAL IMPAIRMENT (Cant think) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014-C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in January 2021. Concomitant products included CALCIUM and ALENDRONATE SODIUM (FOSAMAX) for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced MENTAL IMPAIRMENT (Cant think) (seriousness criterion medically significant), PAIN IN EXTREMITY (Pain in arm), FEELING ABNORMAL (Fuzzy head), MYALGIA (Arm pain,achy and everything,bodyache), HEADACHE (slight headache), CHILLS (chills) and NAUSEA (feeling nauseous). At the time of the report, MENTAL IMPAIRMENT (Cant think), PAIN IN EXTREMITY (Pain in arm), FEELING ABNORMAL (Fuzzy head), MYALGIA (Arm pain,achy and everything,bodyache), HEADACHE (slight headache), CHILLS (chills) and NAUSEA (feeling nauseous) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication includes Liver supplement (herb). Treatment information was not reported.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Injection site redder and larger by the day; Extremely painful; Injection arm 2 inchers larger than other arm; site temp 101; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Injection arm 2 inchers larger than other arm), VACCINATION SITE WARMTH (site temp 101), VACCINATION SITE ERYTHEMA (Injection site redder and larger by the day) and VACCINATION SITE PAIN (Extremely painful) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M20A and 024M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PERIPHERAL SWELLING (Injection arm 2 inchers larger than other arm), VACCINATION SITE WARMTH (site temp 101) and VACCINATION SITE PAIN (Extremely painful). On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Injection site redder and larger by the day). At the time of the report, PERIPHERAL SWELLING (Injection arm 2 inchers larger than other arm), VACCINATION SITE ERYTHEMA (Injection site redder and larger by the day) and VACCINATION SITE PAIN (Extremely painful) outcome was unknown and VACCINATION SITE WARMTH (site temp 101) was resolving.            No relevant concomitant medications were reported. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not applicable.
On Day three of vaccine given Redness and swelling to left side of the face, headaches, tingling and numbness and pain to left face, pain left side of neck, followed by twitching and pressure of left eye,
Within a few hours I experienced severe fatigue, which progressed to body aches, headache, and fever.  I was unable to get out the bed for over 24 hours.  Once the fever and headache subsided, I had increasing chest pain/pressure.  When the fatigue and chest pain did not subside after a week, I scheduled a doctor's appointment to address the symptoms.  I also noticed that I had an odd assortment of bruises that appeared without a cause.  After about 2 weeks after the vaccine the chest pain subsided.  My first menstrual cycle after taking the vaccine came a week earlier than it should have and was extremely heavy.
Went to monthly ob/gyn check-up on 12/17 and no heartbeat was detected...Was 16 weeks pregnant. On 12/18, had D&C procedure done. Went to ER on 1/30/10 and had a D&C procedure done as body still was bleeding and was passing clots...still remaining tissue in uterus.
Client at clinic for kindergarten immunizations with DTAP #5 administered to right deltoid.  Mother reports no symptoms or complaints to site till 2 days post vaccination.  Mother reports swelling, redness, and heat to site where DTAP was administered.  Mother states no relief to symptoms with use of pain meds and other comfort measures.  No other symptoms present per mother.  Encouraged to follow up with child's primary physician.  Mother states follow up done with primary physician with order to continue comfort measures.  No other orders from child's doctor for follow up per Mother.
28mar90 pt vax hepta b. pt ex joint aching, and nausea which remitted w/i few days. attrib. aches to cocurrent viral syndrome. 07may90 2nd vax. 01jun90 pt devel swelling in ankles and hand joints. also complained of arthritic sx in hip/knee
This case involves a patient (unknown demographics) who had flu (influenza), after receiving INFLUENZA VACCINE. The patient's medical history, past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route at an unknown administration site for prophylactic vaccination. On an unknown date the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE. It was reported I got my flu shot two weeks ago and now I'm at home with full blown flu, never again. Details of laboratory were not reported. It was not reported if the patient received any corrective treatment for the event. At time of reporting, the outcome was unknown for the event.
vaccine stored outside of recommended range were administered to patient; No additional AE details; This spontaneous report was received from an administrator and referred to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. Concomitant medication included sterile diluent.  On an unknown date, the patient was vaccinated with the improperly stored (stored outside of recommended range) measles, mumps, rubella and varicella (oka-merck) virus vaccine (live recombinant human albumin (rHA)) (PROQUAD) (lot #U039258, expiration date: 09-JUN-2023) for prophylaxis (strength, dose, and route of administration were not provided) (product storage error).  It was reported that the suspect vaccine was exposed to a temperature of 6 Fahrenheit (F) up to 14 F (7.9 F) for a time frame of 4 hours, 8 minutes, and 0 second. There were no previous temperature excursions. No digital data logger was reported.  No additional adverse event (AE) details was provided (no adverse event).   This is one of the several cases reported by the same reporter.; Sender's Comments:  US-009507513-2205USA001202:
Information has been received from a physician concerning her 6 yr old daughter with no medical history who, at one year of age, in 2000, was vaccinated with a dose of varicella virus vaccine live. On 28Feb06, the pt developed a rash of over 100 lesions. It was not reported over what body areas the rash appeared. No other symptoms were reported. Unspecified medical attention was sought. At the time of the report, the child was recovering and no treatment was necessary per the physician. A product quality complaint was not involved. Follow up information was received from the physician who reported that on 28Feb06, her daughter developed breakthrough chickenpox. Additional information has been requested. The physician also reported that her 15 month old daughter experienced chickenpox following vaccination with varicella virus vaccine live (WAES0603USA02407). Additional information has been received from the physician indicating that her 6-year-old daughter was vaccinated on 26-JUL-2000 with a dose of VARIVAX. On 28-FEB-2006, the patient developed a varicella rash of approximately 7- lesions. No fever. Some itching. The patient missed school days and had the appearance scarring. It was reported the patient recovered as of 06-MAY-2006.
Information has been received from a physician concerning a 19 year old female who about a year ago (in approximately 2008) was vaccinated with the third dose of GARDASIL (dose, route and lot number not reported). The physician reported that the patient's mother reported to him that soon after receiving the third dose of GARDASIL (in approximately 2008), the patient experienced nausea, weight loss, fatigue and joint pain. The physician reported that the patient was sent to see a rheumatologist and the results came back fine. The physician reported that the patient had recovered and was fine. The patient sought medical attention by contacting the physician. Additional information has been requested.
103 temp, fussy, n/v/d X 2-3 days. Parents stated "shaking head against things like his head was hurting".
pain in the upper left arm pain and difficulty to lift the arm Takes advil 4000mg two to three times daily for months.  trial of steroid with blood sugar precautions for diabetes and MRI warranted